LIGHTSTONE VENTURES
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.
LIGHTSTONE VENTURES
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2012-01-01
Status:
Active
Contact:
617.933.3769
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Gurnet Point Capital
Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies
Hitachi Ventures
Hitachi Ventures is the global venture capital arm of Hitachi Group
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Sanofi Ventures
Sanofi Ventures operates as the corporate venture capital arm of Sanofi.
Current Advisors List
Advisor
2013-05-01
Current Employees Featured
Ken Noonan CEO, Lightstone Singapore Pte. Ltd. @ Lightstone Ventures
CEO, Lightstone Singapore Pte. Ltd.
2015-11-01
Christina Isacson Partner @ Lightstone Ventures
Partner
2021-03-01
Jason Lettmann General Partner @ Lightstone Ventures
General Partner
2012-03-01
Jean George General Partner @ Lightstone Ventures
General Partner
Stephanie White Controller @ Lightstone Ventures
Controller
2018-06-01
Stacy Enxing Seng Venture Partner @ Lightstone Ventures
Venture Partner
Christopher M. Owens Founder, President & CEO @ Lightstone Ventures
Founder, President & CEO
Hank Plain Partner @ Lightstone Ventures
Partner
2012-01-01
Robin Bellas Partener @ Lightstone Ventures
Partener
2012-01-01
Caroline Gaynor Vice President @ Lightstone Ventures
Vice President
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-11 | ProVerum Medical | Lightstone Ventures investment in Series A - ProVerum Medical | 30 M EUR |
| 2021-12-27 | Choiceform | Lightstone Ventures investment in Venture Round - Choiceform | 30 M USD |
| 2021-08-18 | Vigil Neuroscience | Lightstone Ventures investment in Series B - Vigil Neuroscience | 90 M USD |
| 2021-04-15 | Alchemab Therapeutics | Lightstone Ventures investment in Series A - Alchemab Therapeutics | 60 M GBP |
| 2021-04-01 | WayCool | Lightstone Ventures investment in Series C - WayCool | 20 M USD |
| 2021-02-11 | Cyteir Therapeutics | Lightstone Ventures investment in Series C - Cyteir Therapeutics | 80 M USD |
| 2021-02-08 | Gemini Therapeutics | Lightstone Ventures investment in Post-IPO Equity - Gemini Therapeutics | 95 M USD |
| 2021-01-04 | Ligature Therapeutics | Lightstone Ventures investment in Seed Round - Ligature Therapeutics | 6 M USD |
| 2020-12-16 | Atsena Therapeutics | Lightstone Ventures investment in Series A - Atsena Therapeutics | 55 M USD |
| 2020-12-14 | Locanabio | Lightstone Ventures investment in Series B - Locanabio | 100 M USD |
More informations about "Lightstone Ventures"
Lightstone Ventures - Crunchbase Investor Profile
Lightstone Ventures may be growing as evidenced by the closure of a significant $50 million fund focused on Singapore. This financial milestone indicates an expansion of the firm's investment activities and an increase in available …See details»
Lightstone Ventures - The Org
Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially meaningful therapies. We invest in biotech and …See details»
Lightstone Ventures - LinkedIn
Lightstone Ventures | 3,137 followers on LinkedIn. Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially ...See details»
Lightstone Ventures investment portfolio - PitchBook
Lightstone Ventures General Information Company Description. Founded in 2012, Lightstone Ventures is a venture capital firm based in Menlo Park, California. The firm invests in early-stage and late-stage healthcare, life science, medical …See details»
Lightstone Ventures - Investments, Portfolio & Company Exits
Lightstone Ventures 's most notable exits include ALX Oncology, Bold Penguin, and Vigil Neuroscience. Which industries has this organization had the most exits in? Show . ALX …See details»
Lightstone Ventures - Contacts, Employees, Board Members
Lightstone Ventures has 15 current employee profiles, including CEO, Lightstone Singapore Pte. Ltd. Ken Noonan. Lightstone Ventures has 1 board member or advisor, Richard Popp. …See details»
Lightstone Ventures – 65LAB
Lightstone Ventures is a global venture capital firm investing in biotech and medtech companies pioneering big ideas poised to transform patient outcomes. We were founded in 2012 to …See details»
Lightstone Ventures - vcinvestorlist.com
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Number of Investments: 67 Number of Exits: 12 Investment Industries: …See details»
Lightstone Ventures - Private Equity List
Lightstone Ventures was founded in 2012, when the healthcare teams from Advanced Technology Ventures and Morgenthaler Ventures joined forces, to invest in therapeutic …See details»
Lightstone Ventures | Institution Profile - Private Equity International
Lightstone Ventures. News, insights, analysis and data. Lightstone Ventures overview. Founded in 2012, Lightstone Ventures is a California-headquartered investment firm that specialises in …See details»
Lightstone Ventures Closes $375 Million Fund - Cooley
Boston – September 24, 2021 – Cooley advised Lightstone Ventures, a global venture capital firm investing in biotech and medtech companies, on the closing of Lightstone Ventures III, an over …See details»
Lightstone Ventures Raises $375 Million Fund
MENLO PARK, Calif., and Boston, September 14, 2021 – Lightstone Ventures today announced the closing of Lightstone Ventures III with $375 million in capital commitments, to invest in …See details»
Lightstone Ventures Raises $375 Million Fund - Markets Insider
Sep 14, 2021 Lightstone Ventures is a global venture capital firm investing in biotech and medtech companies pioneering big ideas poised to transform patient outcomes. We were …See details»
Lightstone Ventures Raises $375 Million Fund - PR Newswire
Sep 14, 2021 MENLO PARK, Calif. and BOSTON, Sept. 14, 2021 /PRNewswire/ -- Lightstone Ventures today announced the closing of Lightstone Ventures III with $375 million in capital …See details»
Lightstone Ventures Portfolio Companies - Crunchbase
Jun 16, 2014 Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. This list of organizations invested in by Lightstone …See details»
After 3 big exits, Lightstone snags largest fund yet with $375M …
Sep 14, 2021 After seeing Ra Pharmaceuticals, Disarm Therapeutics and Tizona Therapeutics to exits last year, Lightstone Ventures is back with $375 million to plant a seed in early-stage …See details»
Lightstone Ventures Closes $250 Million Fund - Cooley
Palo Alto – September 26, 2017 – Cooley advised Lightstone Ventures on the closing of Lightstone Ventures II (LSV II), an over-subscribed fund that exceeded its $200 million target …See details»
Lightstone | Lightstone Ventures | Innovation - Lightstone
Lightstone Ventures is passionate about innovation, particularly within the PropTech, InsureTech, and FinTech space. ... Lightstone has a track record of backing entrepreneurs as both a …See details»
Lightstone Ventures amasses $375m for third fund - Venture …
Sep 14, 2021 Lightstone Ventures has closed its third fund at $375 million. The venture firm invests in in biotech and medtech companies. PRESS RELEASE. MENLO PARK, Calif., and …See details»
Support PhDs building deep-tech ventures | Science - AAAS
Mar 13, 2025 To prepare PhDs to become founders of ventures based on their own research, universities and innovation ecosystem partners must establish dedicated training for and must …See details»